Gastorointestinal Cancer Clinical Cohorts

Comprehensive genomic profiling of colon adenocarcinomas has revealed multiple recurrent alterations that may inform new treatment strategies. Clinical trials of these agents are ongoing, although the mechanisms of response and resistance to these agents are not well characterized. The goal of this study is to perform comprehensive profiling of pre-treatment and post-resistance tumor and germline samples obtained from patients with colon cancer who receive these agents by carrying out whole exome sequencing and RNA sequencing, and to use these data to identify mechanisms of response and resistance.]]>
Samples were collected from patients in the IRB-approved studies. For inclusion, patients had to have a diagnosis of colon cancer and have suitable tissue for profiling.]]>